GRAVEL ROOT GRAY WALLEFLOWER

GRAVEL ROOT (Eupatorium purpureum L.) +

Synonym :
Eupatoriadelphus purpureus (L.) R. M. King & H. Rob.

Activities (Gravel Root) :
Antidote (f; DEM); Antilithic (f; FAD); Antirheumatic (f; PNC); Depurative (f; DEM); Diaphoretic (f; CEB); Diuretic (f; PNC); Hypoglycemic (1; TOM); Laxative (f; DEM); Stimulant (f; PNC).

Indications (Gravel Root) :
Arthrosis (f; JAD); Asthma (f; FAD); Brights Disease (f; TOM); Burn (f; DEM); Calculus (f; CEB; FAD); Cancer (f; JAD); Childbirth (f; DEM); Cold (f; DEM); Constipation (f; DEM); Cough (f; FAD); Cystosis (f; PNC; TOM); Dropsy (f; FAD); Dysuria (f; DEM; PNC); Fever (f; CEB; DEM); Gout (f; CEB; FAD; TOM); Gravel (f; CEB; DEM); Headache (f; TOM); Hysteria (f; DEM); Impotence (f; FAD); Incontinence (f; FAD); Inflammation (f; CEB); Jaundice (f; CEB); Miscarriage (f; DEM); Nephrosis (f; DEM); Neuralgia (f; TOM); Rheumatism (f; DEM; PNC); Sprain (f; DEM); Stone (f; FAD); Typhus (f; CEB; JAD); Urethrosis (f; DEM; FAD); Uterosis (f; FAD); UTI (f; FAD); Water Retention (f; PNC); Wound (f; DEM).

Dosages (Gravel Root) :
2 - 4 g root, or in tea, 3 ×/day (CAN); 2 - 4 ml liquid herbal extract (1:1 in 25% ethanol) 3 ×/day (CAN); 1 - 2 ml herbal tincture (1:5 in 40% ethanol) 3 ×/day (CAN).

Contraindications, Interactions, and Side Effects (Gravel Root) :
Class 2a, 2b, 2c, 2d. Longterm use discouraged (AHP). Effective July 1996, the AHP Board of Trustees recommends that all products with botanical ingredient(s) containing toxic pyrrolizidine alkaloids, including Borago officinalis, display the following cautionary statement on the label, For external use only. Do not apply to broken or abraded skin. Do not use when nursing (AHP). Pyrrolizidine alkaloids (PAs) have genotoxic, carcinogenic, and hepatotoxic activity (CAN). Because of the PAs, its use in
pregnancy and lactation is to be avoided. Animal studies document placental transfer and secretion
into breast milk of unsaturated PAs (CAN). 

 
GRAY WALLFLOWER (Erysimum diffusum Ehrh.) +

Activities (Gray Wallflower) :
Negative Chronotropic (1; PH2); Positive Inotropic (1; PH2).

Indications (Gray Wallflower) :
Cardiopathy (f; HHB; PH2).

Dosages (Gray Wallflower) :
Single dose, 3.3 mg, cardioactive glycosides; maximum daily dose, 6.6 mg (HHB).

Contraindications, Interactions, and Side Effects (Gray Wallflower) :
Not covered (AHP).
Health hazards not known with proper therapeutic dosages (PH2).